Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.64113 | 80 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 6.39413 | 85 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 6.35354 | 85 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 6.36743 | 84 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 6.04023 | 82 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 4.87688 | 75 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.9865 | 84 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.83537 | 81 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.84483 | 81 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 6.21113 | 84 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 6.53036 | 86 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 6.29783 | 84 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 6.20736 | 84 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 6.11851 | 83 |